C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.
Morikawa T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Isobe T, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Yasui T.
Morikawa T, et al. Among authors: etani t.
Cancers (Basel). 2024 Apr 28;16(9):1725. doi: 10.3390/cancers16091725.
Cancers (Basel). 2024.
PMID: 38730675
Free PMC article.